February 17 - 18 , 2016

Videos

In Vitro to In Vivo Extrapolation for High Throughput Prioritization and Decision Making Final Documents
February 17 - 18 , 2016

Federal Register Notices
February 17 - 18 , 2016

In Vitro to In Vivo Extrapolation for High Throughput Prioritization and Decision Making Meeting Materials
February 17 - 18 , 2016

In Vitro to In Vivo Extrapolation for High Throughput Prioritization and Decision Making Presentations
February 17 - 18 , 2016

Workshop Presentations

Opening Session

Session 1: Application in Risk Assessment: What Do We Need for Decision-making and Prioritization?

Session 2: Metabolism and Excretion

Session 3: In Silico Modeling

Summary Presentations

Webinar Materials

October 7: Setting the Stage: Purpose, Definitions, Scope, and Assumptions

Barbara Wetmore, Ph.D., The Hamner Institutes for Health Sciences

November 4: Building Fit-for-purpose Pharmacokinetic Models

John Wambaugh, Ph.D., National Center for Computational Toxicology, U.S. Environmental Protection Agency

December 3: The Role of Pharmacokinetic Model Evaluation

Lisa Sweeney, Ph.D., Naval Medical Research Unit Dayton and Jackson Foundation for the Advancement of Military Medicine

January 6: Framework for Establishing an Internal Threshold of Toxicological Concern

Corie Ellison, Ph.D., Sharon Woods Innovation Center, The Procter & Gamble Company